These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 24355263)

  • 1. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
    Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
    J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
    Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
    Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB).
    Rogers CL; Gibson M; Kern JS; Martin LK; Robertson SJ; Daniel BS; Su JC; Murrell OGC; Feng G; Murrell DF
    JAAD Int; 2021 Mar; 2():134-152. PubMed ID: 34409361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa.
    Jain SV; Harris AG; Su JC; Orchard D; Warren LJ; McManus H; Murrell DF
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):692-698. PubMed ID: 27580431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment.
    Fortuna G; Chainani-Wu N; Lozada-Nur F; Aria M; Cepeda-Valdes R; Pollio A; Marinkovich MP; Martinez-Salazar AE; Mignogna MD; Bruckner AL; Salas-Alanís JC
    J Am Acad Dermatol; 2013 Jan; 68(1):83-92. PubMed ID: 22575158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Birmingham Epidermolysis Bullosa Severity score: development and validation.
    Moss C; Wong A; Davies P
    Br J Dermatol; 2009 May; 160(5):1057-65. PubMed ID: 19434791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB).
    Bruckner AL; Fairclough DL; Feinstein JA; Lara-Corrales I; Lucky AW; Tolar J; Pope E
    Br J Dermatol; 2018 May; 178(5):1128-1134. PubMed ID: 29341069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese.
    Cestari T; Prati C; Menegon DB; Prado Oliveira ZN; Machado MC; Dumet J; Nakano J; Murrell DF
    Int J Dermatol; 2016 Feb; 55(2):e94-9. PubMed ID: 26474322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.
    Frew JW; Martin LK; Nijsten T; Murrell DF
    Br J Dermatol; 2009 Dec; 161(6):1323-30. PubMed ID: 19681875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa.
    Rodari G; Guez S; Manzoni F; Chalouhi KK; Profka E; Bergamaschi S; Salera S; Tadini G; Ulivieri FM; Spada A; Giavoli C; Esposito S
    Osteoporos Int; 2017 Apr; 28(4):1385-1392. PubMed ID: 28012019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
    Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
    Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Instrument for scoring clinical outcome of research for epidermolysis bullosa: a consensus-generated clinical research tool.
    Schwieger-Briel A; Chakkittakandiyil A; Lara-Corrales I; Aujla N; Lane AT; Lucky AW; Bruckner AL; Pope E
    Pediatr Dermatol; 2015; 32(1):41-52. PubMed ID: 24650374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life and clinical severity in people with epidermolysis bullosa - A proposal for assessing nutritional compromise by body mass index (Birmingham Epidermolysis Bullosa Severity Score).
    Togo CCG; Zidório APC; Sá NM; Dutra ES
    Nutr Hosp; 2024 Apr; 41(2):400-408. PubMed ID: 38149521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population.
    Yuen WY; Frew JW; Veerman K; van den Heuvel ER; Murrell DF; Jonkman MF
    Acta Derm Venereol; 2014 Jul; 94(4):442-7. PubMed ID: 24337132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with epidermolysis bullosa.
    Tabolli S; Sampogna F; Di Pietro C; Paradisi A; Uras C; Zotti P; Castiglia D; Zambruno G; Abeni D
    Br J Dermatol; 2009 Oct; 161(4):869-77. PubMed ID: 19624546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study.
    Kang M; Chen JSC; Radjenovic M; Yang A; Feng GHY; Murrell DF
    Exp Dermatol; 2021 Nov; 30(11):1675-1685. PubMed ID: 33347654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Suchindran C
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):147-58. PubMed ID: 18223373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology.
    Fortuna G; Lozada-Nur F; Pollio A; Aria M; Cepeda-Valdes R; Marinkovich MP; Bruckner AL; Salas-Alanís JC
    J Oral Pathol Med; 2013 Nov; 42(10):733-40. PubMed ID: 23772832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa.
    Esposito S; Guez S; Orenti A; Tadini G; Scuvera G; Corti L; Scala A; Biganzoli E; Berti E; Principi N
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; Deleoz J; Devries DT; Suchindran C
    Am J Ophthalmol; 2004 Aug; 138(2):254-62. PubMed ID: 15289135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.